Utilizing its “Interview with the Innovators” platform, Amyloidosis News has launched a 4-part series of video vignettes with prominent advanced practice transthyretin amyloidosis specialists. The series focuses on the functions of evolutionarily conserved transthyretin, or TTR; destabilization of this protein leading to TTR amyloidosis (ATTR); the optimal approach to address this disease; and objective measures of functional capacity in ATTR-CM.
Stay up to date with Amyloidosis News by subscribing to receive the free AMN e‑Newsletter.